There are conflicting reports on the value of cyclocryotherapy in the management of glaucoma. This retrospective study was 
Included in this study are all available case notes of patients undergoing cyclocryotherapy over a 10-year period up to April 1989. Case records were available from 68 eyes of 64 people. The mean age for all patients was 67 years, range 13-88 years.
A carbon dioxide cryosurgical unit and a 2-5 mm probe were used for all procedures. A full description of the operation was not available for all cases, but where indicated typical parameters were a 60-second single freeze, in 6-8 applications, covering 1800 of the ciliary body.
The patients received topical atropine and corticosteroids postoperatively, and in addition glaucoma medication was continued as necessary.
Results
For the purposes of analysis the cases were categorised as shown in Table 1 . Thirty-eight eyes had neovascular glaucoma, ofwhich 26 were due to a central retinal vein occlusion and seven to diabetes. Nine eyes had aphakic glaucoma, nine had angle closure glaucoma, three had primary open angle glaucoma, and nine had secondary open angle glaucoma. The mean follow-up periods for these groups varied from 2-0 to 6 3 years ( Table 2 ). The aim of treatment in all groups was reduction in intraocular pressure and/or control of pain. This latter consideration applied particularly to the neovascular group, 87% of whom had pain preoperatively.
The mean reduction in intraocular pressure following treatment varied from 7-9 mm Hg in the group with secondary open angle glaucoma to 24-3 mm Hg in those with angle closure (Table  3 ).
An intraocular pressure ofmore than 0 mm Hg but less than 22 mm Hg at one month was taken to indicate control of intraocular pressure. By this criterion the pressure was controlled in 29-4% of eyes overall, ranging from 66-7% in the angle closure The intraocular pressure at one month after operation, or as soon as possible after that, was chosen because the full effect of the procedure should be evident by this time. 4 Although there was a significant reduction in intraocular pressure in all groups, particularly in neovascular and angle/closure glaucoma, pressure control at one month was disappointing, with only 29-4% of eyes controlled overall and only 26 3% controlled in the neovascular group. This is lower than other published series, which report conrol in 55-66% of neovascular glaucoma2356 and 59-67% overall.237 Our results may reflect inadequate technique, since the procedure is performed infrequently, as shown by the record of only 68 such operations over a 10-year period, and experience in the technique is therefore limited. The variation in technique recorded in the case notes supports this notion.
Cyclyocryotherapy decreases aqueous production by damaging the ciliary epithelium and the vascular supply to the ciliary body. The destructive effect depends on the freezing rate and the tissue temperature achieved. At -150C extracellular water crystallises, leading to increased extracellular concentration of electrolytes, with resulting cellular dehydration and disruption. Below -15'C intracellular ice crystals form, causing far greater damage. 4 To ensure placement over the pars plicata a 2 -5 mm probe should be used, and this should be placed 1 mm from the limbus nasally, temporally, and inferiorly, and 1 5 mm superiorly.40 A freeze temperature of -800C is desirable to produce a toxic concentration of electrolytes. 4 The freeze time should be longer than 30 seconds so that the changes occurring in cells can cause permanent damage. At -80'C a 60-second application appears to be most appropriate.3 There is a direct relationship between the extent of treatment and intraocular pressure reduction, and this parallels the histological changes resulting from treatment.9 Most of the serious complications (hypotony, phthisis bulbi) are found after 3600 treatment.3 The initial treatment should therefore be limited to one hemisphere.
Despite poor pressure control in our series, the procedure rendered 71-4% of painful eyes comfortable. This indicates that pain relief from cyclocryotherapy is not due solely to pressure control.
The visual loss from other causes in two of the patients with open angle glaucoma indicates that caution must be exercised when attributing decrease in visual acuity to the cyclocryotherapy. It must be borne in mind that the majority of these patients are elderly (mean 67 years) and that these are unhealthy eyes, many of which have a poor prognosis regardless of treatment. 
